test

Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry

Conditions

Peripheral T-cell Lymphoma

What is the purpose of this trial?

The COMPLETE registry is a prospective, longitudinal, multinational, observational study that will collect data on how patients with peripheral T-cell lymphoma (PTCL) are treated in academic and community practices. The registry will enroll newly-diagnosed patients with PTCL treated with a variety of regimens. The COMPLETE registry is designed to better understand PTCL patient characteristics, treatments, and outcomes to help design and understand future clinical trials.



Participation Guidelines

Age:
N/A - N/A
Gender:
Both

Click here for detailed information about who can participate in this trial.


Sponsor:
Spectrum Pharmaceuticals, Inc
Dates:
February 2010
Last Updated:
February 5, 2014
Study HIC#:

Clinicaltrials.gov ID: NCT01110733